Veracyte reported $170.11M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agenus AGEN:US USD 208.35M 20.03M
Agilent A:US USD 1.05B 18M
Anika Therapeutics ANIK:US USD 87.78M 3.62M
Arrowhead Research ARWR:US USD 108M 31.43M
Bruker BRKR:US USD 626.2M 96.8M
Exact Sciences EXAS:US USD 61.34M 5.14M
Heron Therapeutics HRTX:US USD 50.44M 1.83M
Illumina ILMN:US USD 1000M 289M
Immunogen IMGN:US USD 309.51M 64.36M
Intrexon XON:US USD 9.07M 34.78M
Karyopharm Therapeutics KPTI:US USD 71.35M 10.9M
Laboratory Of America LH:US USD 409.9M 658.9M
Ligand Pharmaceuticals LGND:US USD 121.41M 116.13M
Myriad Genetics MYGN:US USD 110.7M 86.6M
Rigel Pharmaceuticals RIGL:US USD 29.87M 2.66M
Roche Holding ROG:VX 4.32B 2.54B
Sangamo Biosciences SGMO:US USD 94.57M 23.14M
Siemens SIE:GR EUR 10.46B 368M
Thermo Fisher Scientific TMO:US USD 2.92B 1.03B
Veracyte VCYT:US USD 170.11M 16.66M
Waters WAT:US USD 444.51M 25.62M